PLSCR1 and neoplasm: The anticancer microRNA miR-628-5p accelerates tumor suppression in human PDAC, probably by directly targeting the PLSCR1 and insulin receptor substrate 1 (IRS1) genes through inhibition of AKT/NF-κB signal pathways (Zhou et al., 2020).